On Feb. 3, 2014, Thermo Fisher announced it had completed its acquisition of Life Technologies for $76.13 in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of $1.5 billion in net debt.

Life Technologies was created by the merger of Invitrogen and Applied Biosystems in November of 2008.

.